Metis Global Partners LLC Has $15.92 Million Stock Position in UnitedHealth Group Incorporated $UNH

Metis Global Partners LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 13.1% in the second quarter, HoldingsChannel.com reports. The firm owned 51,040 shares of the healthcare conglomerate’s stock after selling 7,698 shares during the quarter. Metis Global Partners LLC’s holdings in UnitedHealth Group were worth $15,923,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Legacy Wealth Managment LLC ID boosted its holdings in UnitedHealth Group by 504.8% in the second quarter. Legacy Wealth Managment LLC ID now owns 508 shares of the healthcare conglomerate’s stock valued at $159,000 after acquiring an additional 424 shares during the last quarter. Summit Wealth & Retirement Planning Inc. acquired a new position in UnitedHealth Group during the 2nd quarter valued at about $292,000. Penserra Capital Management LLC grew its position in shares of UnitedHealth Group by 24.8% during the 2nd quarter. Penserra Capital Management LLC now owns 9,586 shares of the healthcare conglomerate’s stock worth $2,990,000 after buying an additional 1,902 shares during the period. Marco Investment Management LLC lifted its holdings in UnitedHealth Group by 50.8% in the second quarter. Marco Investment Management LLC now owns 55,654 shares of the healthcare conglomerate’s stock valued at $17,362,000 after buying an additional 18,739 shares during the period. Finally, Kinsale Capital Group Inc. acquired a new stake in UnitedHealth Group during the 2nd quarter worth $8,480,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.8%

UNH opened at $324.29 on Friday. The firm’s fifty day simple moving average is $345.84 and its 200 day simple moving average is $323.37. The stock has a market capitalization of $293.75 billion, a P/E ratio of 16.93, a P/E/G ratio of 2.28 and a beta of 0.47. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period in the previous year, the company posted $7.15 earnings per share. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s payout ratio is currently 46.14%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of analyst reports. TD Cowen lifted their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research note on Thursday, October 30th. Royal Bank Of Canada boosted their target price on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Leerink Partners set a $410.00 price target on shares of UnitedHealth Group and gave the company an “outperform” rating in a research report on Wednesday, October 29th. Mizuho increased their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Finally, Oppenheimer decreased their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.